Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3026% below fair value
$17.46+0.66 (+3.93%)
Close on Nov 20, 2026Market cap $1.21BP/E –Yield –
Tandem Diabetes Care shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Tandem Diabetes Care's shares outstanding was 69M at Jun 30, 2026. For fiscal 2025 it was 67M, up 2.8% from the year before. Over ten years it grew 37.0% a year on average. The highest annual figure on record is 67M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67M | +2.8% |
| FY2024 | Dec 31, 2024 | 65M | +0.7% |
| FY2023 | Dec 31, 2023 | 65M | +1.3% |
| FY2022 | Dec 31, 2022 | 64M | -0.3% |
| FY2021 | Dec 31, 2021 | 64M | +5.5% |
| FY2020 | Dec 31, 2020 | 61M | +4.2% |
| FY2019 | Dec 31, 2019 | 59M | +21.6% |
| FY2018 | Dec 31, 2018 | 48M | +747.8% |
| FY2017 | Dec 31, 2017 | 6M | +85.7% |
| FY2016 | Dec 31, 2016 | 3M | +5.7% |
| FY2015 | Dec 31, 2015 | 3M | +24.3% |
| FY2014 | Dec 31, 2014 | 2M | +691.0% |
| FY2013 | Dec 31, 2013 | 0M | +1464.9% |
| FY2012 | Dec 31, 2012 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 69M | +2.9% |
| Q1 FY2026 | Mar 31, 2026 | 68M | +3.0% |
| Q4 FY2025 | Dec 31, 2025 | 68M | +2.8% |
| Q3 FY2025 | Sep 30, 2025 | 68M | +3.2% |
| Q2 FY2025 | Jun 30, 2025 | 67M | +3.2% |
| Q1 FY2025 | Mar 31, 2025 | 66M | +1.7% |
| Q4 FY2024 | Dec 31, 2024 | 66M | +1.2% |
| Q3 FY2024 | Sep 30, 2024 | 66M | +0.6% |
| Q2 FY2024 | Jun 30, 2024 | 65M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | 65M | +1.2% |
| Q4 FY2023 | Dec 31, 2023 | 65M | +1.5% |
| Q3 FY2023 | Sep 30, 2023 | 65M | +1.4% |
| Q2 FY2023 | Jun 30, 2023 | 65M | +1.2% |
| Q1 FY2023 | Mar 31, 2023 | 65M | +1.0% |
| Q4 FY2022 | Dec 31, 2022 | 64M | -2.3% |
| Q3 FY2022 | Sep 30, 2022 | 64M | -0.8% |
| Q2 FY2022 | Jun 30, 2022 | 64M | -2.4% |
| Q1 FY2022 | Mar 31, 2022 | 64M | +2.3% |
| Q4 FY2021 | Dec 31, 2021 | 66M | +0.4% |
| Q3 FY2021 | Sep 30, 2021 | 65M | +5.3% |
| Q2 FY2021 | Jun 30, 2021 | 66M | +8.7% |
| Q1 FY2021 | Mar 31, 2021 | 62M | +4.5% |
| Q4 FY2020 | Dec 31, 2020 | 66M | +4.4% |
| Q3 FY2020 | Sep 30, 2020 | 62M | +3.9% |
| Q2 FY2020 | Jun 30, 2020 | 60M | +3.8% |
| Q1 FY2020 | Mar 31, 2020 | 60M | +3.4% |
| Q4 FY2019 | Dec 31, 2019 | 63M | +9.3% |
| Q3 FY2019 | Sep 30, 2019 | 59M | +6.4% |
| Q2 FY2019 | Jun 30, 2019 | 58M | +14.3% |
| Q1 FY2019 | Mar 31, 2019 | 58M | +221.1% |
| Q4 FY2018 | Dec 31, 2018 | 58M | +518.4% |
| Q3 FY2018 | Sep 30, 2018 | 56M | +971.6% |
| Q2 FY2018 | Jun 30, 2018 | 51M | +918.1% |
| Q1 FY2018 | Mar 31, 2018 | 18M | +464.2% |
| Q4 FY2017 | Dec 31, 2017 | 9M | +201.4% |
| Q3 FY2017 | Sep 30, 2017 | 5M | +69.4% |
| Q2 FY2017 | Jun 30, 2017 | 5M | – |
| Q1 FY2017 | Mar 31, 2017 | 3M | – |
| Q4 FY2016 | Dec 31, 2016 | 3M | – |
| Q3 FY2016 | Sep 30, 2016 | 3M | – |
See a number that looks wrong?